Please login to the form below

Not currently logged in

Martin Reeves joins Oxford BioDynamics

He takes up a senior vice president role

Martin ReevesOxford BioDynamics – a spin out company from the University of Oxford – has appointed Martin Reeves as its new senior vice president, commercial development.

His career to date has seen him hold positions such as head of business development, global branded products at Teva Pharmaceuticals, VP of business development and strategic planning at Cephalon and various project management roles at Wyeth-Ayerst and SmithKline Beecham.

Christian Hoyer Millar, CEO at Oxford BioDynamics, said: “His considerable experience in business development within the sector will be a great asset to Oxford BioDynamics as we look to leverage IP licensing opportunities with our award-winning, proprietary technology platform EpiSwitch.”

23rd March 2017

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
FCB Halesway

A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...

Latest intelligence

Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?
The Biosimilar Challenge